Biotest Aktiengesellschaft Working Capital to Net Assets Ratio
Biotest Aktiengesellschaft working capital to net assets ratio. Biotest Aktiengesellschaft (BIO) has a Working Capital to Net Assets ratio of 123.4% as of March 2025. Working capital of €628.60 Million (current assets of €788.70 Million minus current liabilities of €160.10 Million) is measured against net assets of €509.60 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Biotest Aktiengesellschaft (2002–2024)
Working capital to net assets ratio of Biotest Aktiengesellschaft from 2002 to 2024. This chart shows how Biotest Aktiengesellschaft's Working Capital to Net Assets ratio has evolved across 20 annual periods from 2002 to 2024. As of March 2025, the ratio stands at 123.4%, reflecting working capital of €628.60 Million against net assets of €509.60 Million EUR. Explore BIO strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Biotest Aktiengesellschaft Working Capital to Net Assets Ratio by Year (2002–2024)
Biotest Aktiengesellschaft working capital to net assets ratio by year from 2002 to 2024. The table below presents the year-by-year Working Capital to Net Assets ratio for Biotest Aktiengesellschaft from 2002 to 2024, covering 20 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Biotest Aktiengesellschaft (BIO) total assets.
| Year | WC/NA Ratio | Working Capital (EUR) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 122.4% | €649.40 Million | €530.70 Million | €809.50 Million | €160.10 Million | ▲ +48.0 pp |
| 2023 | 74.4% | €371.20 Million | €498.90 Million | €756.50 Million | €385.30 Million | ▼ -57.4 pp |
| 2022 | 131.8% | €489.20 Million | €371.10 Million | €619.40 Million | €130.20 Million | ▲ +22.5 pp |
| 2021 | 109.3% | €415.80 Million | €380.40 Million | €522.20 Million | €106.40 Million | ▲ +7.2 pp |
| 2020 | 102.1% | €450.70 Million | €441.60 Million | €556.30 Million | €105.60 Million | ▲ +16.6 pp |
| 2019 | 85.5% | €407.80 Million | €476.90 Million | €522.80 Million | €115.00 Million | ▲ +10.9 pp |
| 2018 | 74.6% | €369.50 Million | €495.20 Million | €495.10 Million | €125.60 Million | ▲ +17.5 pp |
| 2017 | 57.1% | €198.50 Million | €347.80 Million | €449.70 Million | €251.20 Million | ▼ -32.0 pp |
| 2016 | 89.0% | €321.20 Million | €360.70 Million | €467.20 Million | €146.00 Million | ▼ -22.8 pp |
| 2015 | 111.8% | €461.00 Million | €412.30 Million | €586.80 Million | €125.80 Million | ▼ -2.8 pp |
| 2014 | 114.6% | €550.40 Million | €480.20 Million | €679.30 Million | €128.90 Million | ▲ +19.5 pp |
| 2013 | 95.1% | €438.20 Million | €460.70 Million | €562.50 Million | €124.30 Million | ▲ +40.3 pp |
| 2012 | 54.8% | €202.58 Million | €369.43 Million | €367.46 Million | €164.88 Million | ▼ -9.3 pp |
| 2011 | 64.1% | €222.22 Million | €346.67 Million | €369.95 Million | €147.74 Million | ▲ +6.4 pp |
| 2010 | 57.7% | €177.60 Million | €307.61 Million | €308.94 Million | €131.35 Million | ▼ -7.7 pp |
| 2009 | 65.4% | €176.48 Million | €269.86 Million | €325.26 Million | €148.78 Million | ▲ +1.8 pp |
| 2008 | 63.6% | €161.15 Million | €253.37 Million | €279.49 Million | €118.34 Million | ▼ -104.3 pp |
| 2004 | 167.9% | €181.27 Million | €107.97 Million | €197.86 Million | €16.59 Million | ▼ -8.7 pp |
| 2003 | 176.6% | €182.39 Million | €103.29 Million | €197.21 Million | €14.82 Million | ▼ -2.7 pp |
| 2002 | 179.3% | €198.62 Million | €110.79 Million | €220.67 Million | €22.05 Million | — |